Parker-Hannifin Reports Record Q2 Results, Raises Full-Year Guidance on Strong Demand
PH sits 93% above its 52-week low of $488.45 on elevated volume (2.0× avg).
Summary
Parker-Hannifin reported record second-quarter sales and adjusted EPS, driven by strong organic growth and expanded margins, leading the company to increase its full-year financial outlook.
Key Events · Earnings and Guidance · PH
-
Record Q2 Performance
Achieved record sales of $5.2 billion, a 9% increase, and record adjusted diluted EPS of $7.65, up 17% compared to the prior year period.
-
Strong Organic Growth & Margins
Organic sales increased 6.6% across all reported businesses, with adjusted segment operating margin expanding by 150 basis points to 27.1%.
-
Increased Full-Year Guidance
Raised fiscal year 2026 adjusted EPS guidance to a range of $30.40 to $31.00, reflecting robust aerospace demand and continued industrial market recovery.
-
Record Backlog
Company backlog increased to a record $11.7 billion, with overall order rates up 9%.
Analysis · PH · Manufacturing
Parker-Hannifin's latest 8-K filing signals robust operational strength and positive momentum, with the company delivering record second-quarter sales and adjusted earnings per share. The significant expansion in adjusted segment operating margin, coupled with broad-based organic sales growth across all businesses, underscores effective execution of its "Win Strategy." The decision to raise full-year guidance for sales, operating margin, and adjusted EPS reflects management's confidence in sustained strong aerospace demand and a continued recovery in industrial markets. The record $11.7 billion backlog further supports a positive outlook, suggesting continued revenue visibility and operational stability. This strong performance, while the stock trades near its 52-week high, reinforces investor confidence in the company's strategic direction and market position.
At the time of this filing, PH was trading at $945.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $115.6B. The 52-week trading range was $488.45 to $954.30. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.